E

Business Context and Reporting Period

Company: ENI S.p.A.
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: Second Quarter (Q2) and First Half (H1) ended June 30, 2024.
Filing Date: July 26, 2024.

Eni reported unaudited consolidated results for Q2 and H1 2024, highlighting strong production growth, portfolio rationalization, and progress in transition businesses (Enilive and Plenitude). The Board approved the first tranche of the 2024 dividend provision.

Key Financial Metrics

Production: Hydrocarbon production averaged 1.71 million boe/d in Q2 2024 (+6% YoY). Renewable installed capacity reached 3.1 GW (+24% YoY).

Material Changes vs. Prior Period

• Profitability: Adjusted net profit attributable to shareholders decreased 21% in Q2 and 36% in H1 compared to the prior year, primarily due to lower results in the Global Gas & LNG Portfolio (GGP) and adverse conditions in the Chemicals segment, partially offset by strong E&P performance.
• Segment Performance:
  • E&P: Proforma adjusted EBIT rose 26% in Q2 to €3.5 billion, driven by production growth and higher crude realizations.
  • GGP: Proforma adjusted EBIT fell 71% in Q2 to €0.3 billion due to less favorable price scenarios and the absence of one-off negotiation benefits seen in 2023.
  • Chemicals: Versalis reported a loss of €222 million in Q2, impacted by weak demand and high production costs.
  • Enilive & Plenitude: Combined proforma adjusted EBIT increased 14% in H1 to €0.7 billion, driven by renewable capacity ramp-up and bio-refinery throughput growth.
• Balance Sheet: Net borrowings increased by €2.6 billion to €12.1 billion as of June 30, 2024, largely due to the Neptune Energy acquisition and working capital needs, though leverage remains low at 0.22.

Guidance, Outlook, and Management Commentary

• Dividends: The Board approved the first quarterly dividend tranche of €0.25 per share (total 2024 dividend €1.00), payable September 25, 2024. This represents a 6% increase over 2023.
• Share Buybacks: Management confirmed the €1.6 billion buyback program for 2024 but intends to accelerate the pace. An additional €500 million buyback may be evaluated in Q3 if debt levels permit.
• Financial Targets:
  • Full-year Proforma Adjusted EBIT guidance raised to ~€15 billion.
  • Full-year Adjusted CFFO before working capital expected to exceed €14 billion.
  • Full-year leverage expected to be well below 20% (originally 20-25%), potentially reaching ~15% on a proforma basis.
• Strategic Moves:
  • Agreed to divest Alaska assets to Hilcorp and onshore Nigeria assets.
  • Announced a transformational combination with Ithaca Energy for UK assets.
  • Exclusivity agreement signed with KKR for a 20-25% stake in Enilive (valued €11.5-12.5 billion).
• Risks: Forward-looking statements are subject to risks including commodity price volatility, geopolitical instability, and regulatory changes. Special items in Q2 included €0.5 billion in net charges related to E&P asset writedowns.

Investor Verification Checklist

• Dividend Dates: Verify ex-dividend date (Sept 23, 2024) and payment date (Sept 25, 2024) for the €0.25 tranche.
• Divestment Progress: Monitor closing of Alaska, Nigeria, and UK (Ithaca) transactions to confirm debt reduction trajectory.
• Chemicals Margin: Assess the sustainability of losses in the Versalis segment given the "exceptionally adverse market conditions."
• Buyback Execution: Track the acceleration of the €1.6 billion buyback program and potential additional €500 million allocation.
• Special Items: Review the €1.55 billion in special items for Q2, specifically the €950 million E&P asset writedowns, to understand their impact on future capex and depreciation.